John A. McCaffrey

2.1k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

John A. McCaffrey is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, John A. McCaffrey has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in John A. McCaffrey's work include Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (9 papers) and Testicular diseases and treatments (6 papers). John A. McCaffrey is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (9 papers) and Testicular diseases and treatments (6 papers). John A. McCaffrey collaborates with scholars based in United States, Ireland and Spain. John A. McCaffrey's co-authors include Dean F. Bajorin, Howard I. Scher, Madhu Mazumdar, Harry W. Herr, Geralyn Higgins, Paul M. Dodd, Mary G. Boyle, Madhu Mazumdar, William K. Kelly and Melissa Fazzari and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

John A. McCaffrey

32 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

1999 540 citations Dean F. Bajorin, Paul M. Dodd et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. McCaffrey United States	14	1.4k	464	400	256	175	33	1.6k
Geralyn Higgins United States	8	914 0.7×	271 0.6×	251 0.6×	152 0.6×	99 0.6×	10	996
Christine de Balincourt Belgium	15	1.1k 0.8×	468 1.0×	217 0.5×	152 0.6×	245 1.4×	23	1.4k
Claude Merrin United States	20	612 0.5×	264 0.6×	491 1.2×	84 0.3×	144 0.8×	56	1.1k
Steven J. Nicol United States	14	512 0.4×	503 1.1×	337 0.8×	161 0.6×	161 0.9×	42	1.0k
H. Mildenberger Germany	17	541 0.4×	317 0.7×	262 0.7×	71 0.3×	422 2.4×	48	1.2k
Charles Levenback United States	13	665 0.5×	276 0.6×	124 0.3×	329 1.3×	80 0.5×	17	1.3k
Kiyozo Kishi Japan	18	545 0.4×	364 0.8×	246 0.6×	277 1.1×	153 0.9×	43	1.2k
M. Housset France	17	514 0.4×	345 0.7×	238 0.6×	103 0.4×	170 1.0×	61	1.2k
Erkki Rintala Finland	26	2.2k 1.6×	562 1.2×	473 1.2×	178 0.7×	497 2.8×	41	2.6k
Yuki Fukumura Japan	16	577 0.4×	410 0.9×	239 0.6×	96 0.4×	102 0.6×	90	884

Countries citing papers authored by John A. McCaffrey

Since Specialization

Citations

This map shows the geographic impact of John A. McCaffrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. McCaffrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. McCaffrey more than expected).

Fields of papers citing papers by John A. McCaffrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. McCaffrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. McCaffrey. The network helps show where John A. McCaffrey may publish in the future.

Co-authorship network of co-authors of John A. McCaffrey

This figure shows the co-authorship network connecting the top 25 collaborators of John A. McCaffrey. A scholar is included among the top collaborators of John A. McCaffrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. McCaffrey. John A. McCaffrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Horvath, Lisa G., Ian D. Davis, Andrew Martin, et al.. (2023). 1792P Effects of enzalutamide on overall survival +/- early docetaxel in participants aged less than 70 yrs versus greater than or equal to 70 yrs in ENZAMET (ANZUP 1304). Annals of Oncology. 34. S968–S969. 2 indexed citations

2.

Gravis, Gwénaëlle, Guilhem Roubaud, Ray McDermott, et al.. (2022). 1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial. Annals of Oncology. 33. S1162–S1163. 9 indexed citations

3.

Hegarty, Nicholas J., et al.. (2021). Clear cell urethral adenocarcinoma – a case report of an exceptional response to immunotherapy in a metastatic rare tumour. Journal of Clinical Urology. 16(3). 233–237.

4.

Greally, Megan, et al.. (2018). Indolent Nodal Relapse of Colon Carcinoma with Associated Tumor Thrombus Invading the Superior Mesenteric Vein. Journal of Gastrointestinal Cancer. 50(3). 660–664. 1 indexed citations

5.

Doyle, E., et al.. (2017). Synchronous diffuse large B cell lymphomas of the endometrium and breast: a staging dilemma. Irish Journal of Medical Science (1971 -). 186(4). 867–873. 1 indexed citations

6.

Kelly, D., et al.. (2016). Get the GIST? An overview of gastrointestinal stromal tumours. Irish Journal of Medical Science (1971 -). 185(2). 319–326. 12 indexed citations

7.

Walsh, Elaine M., Michael Farrell, Robert Clarke, et al.. (2015). Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study. Irish Journal of Medical Science (1971 -). 185(1). 189–194. 2 indexed citations

8.

Connolly, Roisín M. & John A. McCaffrey. (2009). High-Dose Chemotherapy plus Stem Cell Transplantation in Advanced Germ Cell Cancer: A Review. European Urology. 56(1). 57–64. 1 indexed citations

9.

Connolly, Roisín M., Paul Downey, & John A. McCaffrey. (2006). Collecting Duct Carcinoma of the kidney: A case report with variable immunohistochemistry. Irish Journal of Medical Science (1971 -). 175(3). 66–68. 1 indexed citations

10.

Leonard, Gregory D., et al.. (2003). Optimal therapy for oesophageal cancer. Cancer Treatment Reviews. 29(4). 275–282. 19 indexed citations

11.

Hennessy, Bryan T., John A. McCaffrey, Peter A. Daly, Paul Browne, & Michael J. Kennedy. (2002). High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy. Irish Journal of Medical Science (1971 -). 171(3). 158–160. 1 indexed citations

12.

Bajorin, Dean F., John A. McCaffrey, Paul M. Dodd, et al.. (2000). Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract. Cancer. 88(7). 1671–1678. 2 indexed citations

13.

Bajorin, Dean F., John A. McCaffrey, Paul M. Dodd, et al.. (2000). Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract. Cancer. 88(7). 1671–1678. 85 indexed citations

14.

Dodd, Paul M., et al.. (2000). Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma. Investigational New Drugs. 18(3). 247–251. 19 indexed citations

15.

Dodd, Paul M., John A. McCaffrey, Madhu Mazumdar, et al.. (2000). Evaluation of Drug Delivery and Survival Impact of Dose-Intense Relative to Conventional-Dose Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy in Urothelial Cancer. Cancer Investigation. 18(7). 626–634. 7 indexed citations

16.

McCaffrey, John A., Dean F. Bajorin, & Robert J. Motzer. (1998). RISK ASSESSMENT FOR METASTATIC TESTIS CANCER. Urologic Clinics of North America. 25(3). 389–395. 9 indexed citations

17.

Bajorin, Dean F., John A. McCaffrey, S Hilton, et al.. (1998). Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.. Journal of Clinical Oncology. 16(8). 2722–2727. 70 indexed citations

18.

McCaffrey, John A., S Hilton, Madhu Mazumdar, et al.. (1997). Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.. Journal of Clinical Oncology. 15(6). 2449–2455. 40 indexed citations

19.

McCaffrey, John A., S Hilton, Madhu Mazumdar, et al.. (1997). Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.. Journal of Clinical Oncology. 15(5). 1853–1857. 298 indexed citations

20.

McCaffrey, John A., Madhu Mazumdar, Dean F. Bajorin, et al.. (1997). Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.. Journal of Clinical Oncology. 15(7). 2559–2563. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact